⌕
Hims & Hers Health · HIMS · NYSE
Tenet 26 · Weak
Compare
$18.56−5.93%At closeTenet 26 · Weak
$18.56−1.17 (−5.93%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD

Hims & Hers Health (HIMS) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineGrowing fast: revenue compounds ~71.4%/yr (FY21→FY25), net margin 5.5%; free cash flow runs at 45% of net income. Check the accrual gap. Worth your attention in FY25: Share count (+38.3%) and Capex step-up ($242.6M). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲59.0%
2,347.6
FY21→FY25CAGR +71.4%/yr
Net income ($M)▲1.8%
128.4
one-off year: see footnoteCAGR —
Free cash flow ($M)▼71.1%
57.4
capex stepped upCAGR —
Diluted EPS▼3.8%
0.51
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+38.3%

186.8mn → 258.2mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex step-up
$242.6M

▲360% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.

Returns vs FCF
157%

$90.0M returned vs $57.4M of FCF in FY25. The gap comes off the balance sheet (see net cash).

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)2347.6Revenue−614.3COGS1733.4Gross profit−149.3R&D−272.7SG&A105.6Op income22.8Tax & other128.4Net income

5¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
906845230%sector median net margin ~4%FY21FY25

Over this window: gross 75.2% → 73.8%. Net margin 5.5% is above the sector median.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
2,869,509.02,347,637.01,476,514.0872,000.0526,916.0271,878.0▲59.0%+71.4%
Cost of revenue
1,038,285.0614,259.0303,379.0157,051.0118,194.067,384.0▲102.5%+73.8%
Gross profit
1,831,224.01,733,378.01,173,135.0714,949.0408,722.0204,494.0▲47.8%+70.6%
Research & development
212,186.0149,301.078,819.048,227.029,237.022,379.0▲89.4%+60.7%
Selling, general & admin
502,692.0272,724.0167,767.0129,883.098,192.0113,662.0▲62.6%+24.5%
Total operating expenses
2,063,699.01,627,765.01,111,232.0744,402.0477,419.0319,536.0▲46.5%+50.2%
Operating incomefeeds ROC rank
−232,475.0105,613.061,903.0−29,453.0−68,697.0−115,042.0▲70.6%—
Other income, net
10,394.018,311.09,808.07,882.02,988.04,247.0——
Pretax income
−222,081.0123,924.071,711.0−21,571.0−65,709.0−110,795.0▲72.8%—
Income tax
−31,237.0−4,441.0−54,327.01,975.0−31.0−3,136.0▲91.8%—
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
−190,844.0128,365.0126,038.0−23,546.0−65,678.0−107,659.0▲1.8%—
Per share
Diluted EPSbuyback-sensitive
−0.830.510.53−0.11−0.32−0.58▼3.8%—
Diluted shares (mn)
233.82258.23236.81209.34204.52186.78▲9.0%+8.4%
Margins
Gross margin45th pct in Healthcare
63.8%73.8%79.5%82.0%77.6%75.2%▼5.6pp−1.4pp
Operating margin
−8.1%4.5%4.2%−3.4%−13.0%−42.3%▲0.3pp+46.8pp
Net margin29th pct in Healthcare
−6.7%5.5%8.5%−2.7%−12.5%−39.6%▼3.1pp+45.1pp
† TTM = trailing four quarters through 2026-09-30.FY24 effective tax rate was −76% vs a −4% norm for this window, likely a one-time item; see the filing.
FY19 – FY20 · 2 more years
Unlock the full history →
2 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-23 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Hims & Hers Health's revenue last fiscal year?

Hims & Hers Health reported revenue of $2,347.6M in fiscal 2025, up 59.0% from fiscal 2024.

What was Hims & Hers Health's net income?

Hims & Hers Health reported net income of $128.4M in fiscal 2025, a net margin of 5.5%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.